Microvascular disease in diabetes and severe COVID-19 outcomes.
作者信息
Corcillo Antonella, Whyte Martin B, Vas Prashanth, Karalliedde Janaka
机构信息
School of Cardiovascular Medicine & Sciences, King's College London, London, SE1 9NH, UK; Department of Diabetes, Guy's and St Thomas NHS Foundation Trust, Guy's Hospital, London, UK.
Department of Diabetes, King's College NHS Foundation Trust, London, UK; Department of Clinical and Experimental Medicine, University of Surrey, UK.
出版信息
Lancet Diabetes Endocrinol. 2021 Apr;9(4):200-201. doi: 10.1016/S2213-8587(21)00053-X.
Abstract
摘要
相似文献
1
Microvascular disease in diabetes and severe COVID-19 outcomes.糖尿病中的微血管疾病与严重的2019冠状病毒病结局
Lancet Diabetes Endocrinol. 2021 Apr;9(4):200-201. doi: 10.1016/S2213-8587(21)00053-X.
2
Microvascular disease in diabetes and severe COVID-19 outcomes - Authors' reply.糖尿病中的微血管疾病与严重的新冠病毒病结局——作者回复
Lancet Diabetes Endocrinol. 2021 Apr;9(4):201. doi: 10.1016/S2213-8587(21)00055-3.
3
Observational research on severe COVID-19 in diabetes.糖尿病患者中重症新冠肺炎的观察性研究。
Lancet Diabetes Endocrinol. 2021 Feb;9(2):56-57. doi: 10.1016/S2213-8587(20)30432-0. Epub 2020 Dec 23.
4
Is newly diagnosed diabetes a stronger risk factor than pre-existing diabetes for COVID-19 severity?对于新冠病毒疾病（COVID-19）的严重程度而言，新诊断出的糖尿病比已存在的糖尿病是更强的风险因素吗？
J Diabetes. 2021 Feb;13(2):177-178. doi: 10.1111/1753-0407.13125. Epub 2020 Nov 9.
5
Diabetes mellitus and SARS-CoV-2-related mortality: the impact of acute hyperglycemic crises and some further considerations.糖尿病与新型冠状病毒肺炎相关死亡率：急性高血糖危象的影响及一些进一步的思考
Acta Diabetol. 2021 Jan;58(1):125-126. doi: 10.1007/s00592-020-01593-7. Epub 2020 Aug 20.
6
Predicting Mortality Due to SARS-CoV-2: A Mechanistic Score Relating Obesity and Diabetes to COVID-19 Outcomes in Mexico.预测因 SARS-CoV-2 导致的死亡率：一个将肥胖和糖尿病与墨西哥 COVID-19 结局相关联的机制评分。
J Clin Endocrinol Metab. 2020 Aug 1;105(8). doi: 10.1210/clinem/dgaa346.
7
Response to: Is newly diagnosed diabetes a stronger risk factor than pre-existing diabetes for COVID-19 severity?回应：对于新冠病毒疾病（COVID-19）的严重程度而言，新诊断出的糖尿病比已患糖尿病是更强的风险因素吗？
J Diabetes. 2021 Feb;13(2):179-180. doi: 10.1111/1753-0407.13127. Epub 2020 Nov 18.
8
Glucovigilance in COVID-19.2019冠状病毒病中的血糖监测
J Pak Med Assoc. 2020 May;70(Suppl 3)(5):S80-S82. doi: 10.5455/JPMA.15.
9
Inflammation and hypercoagulopathy are predominant risk factors of severity in COVID-19 patients with diabetes mellitus: Summary of a meta-analysis.炎症和高凝状态是糖尿病合并COVID-19患者病情严重程度的主要危险因素：一项荟萃分析综述
Diabetes Metab Syndr. 2021 Mar-Apr;15(2):639-641. doi: 10.1016/j.dsx.2021.02.021. Epub 2021 Feb 24.
10
Are diabetes and its medications risk factors for the development of COVID-19? Data from a population-based study in Sicily.糖尿病及其药物是否是 COVID-19 发展的危险因素？西西里岛一项基于人群的研究数据。
Nutr Metab Cardiovasc Dis. 2021 Feb 8;31(2):396-398. doi: 10.1016/j.numecd.2020.09.028. Epub 2020 Oct 1.
引用本文的文献
1
Microvascular disease and severe COVID-19 outcomes in UKBiobank participants with diabetes.英国生物银行中患有糖尿病的参与者的微血管疾病与严重新冠病毒病结局
Acta Diabetol. 2025 Mar;62(3):293-301. doi: 10.1007/s00592-024-02420-z. Epub 2024 Nov 21.
2
Endothelium dysfunction and thrombosis in COVID-19 with type 2 diabetes.2 型糖尿病合并 COVID-19 患者的血管内皮功能障碍与血栓形成。
Endocrine. 2023 Oct;82(1):15-27. doi: 10.1007/s12020-023-03439-y. Epub 2023 Jul 1.
3
Pre-existing diabetic retinopathy as a prognostic factor for COVID-19 outcomes amongst people with diabetes: A systematic review.糖尿病患者中预先存在的糖尿病视网膜病变作为 COVID-19 结局的预测因素：系统评价。
Diabetes Res Clin Pract. 2022 May;187:109869. doi: 10.1016/j.diabres.2022.109869. Epub 2022 Apr 5.
4
The management of type 2 diabetes before, during and after Covid-19 infection: what is the evidence?新冠病毒感染前后 2 型糖尿病的管理：有哪些证据？
Cardiovasc Diabetol. 2021 Oct 1;20(1):198. doi: 10.1186/s12933-021-01389-1.
Zotero 插件